Cargando…
LC/MS-Based Global Metabolomic Identification of Serum Biomarkers Differentiating Hepatocellular Carcinoma from Chronic Hepatitis B and Liver Cirrhosis
[Image: see text] Chronic hepatitis B virus (CHB) infection is one of the primary risk factors associated with the development of hepatocellular carcinoma (HCC). Despite having been extensively studied, diagnosing early-stage HCC remains challenging, and diagnosed patients have a poor (3–5%) surviva...
Autores principales: | Pan, Hong Y., Wu, Qing Q., Yin, Qiao Q., Dai, Yi N., Huang, Yi C., Zheng, Wei, Hui, Tian C., Chen, Mei J., Wang, Ming S., Zhang, Jia J., Huang, Hai J., Tong, Yong X. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical Society
2021
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7818305/ https://www.ncbi.nlm.nih.gov/pubmed/33490775 http://dx.doi.org/10.1021/acsomega.0c04259 |
Ejemplares similares
-
LC–MS-based serum metabolomics analysis for the screening and monitoring of colorectal cancer
por: Yi, Yanan, et al.
Publicado: (2023) -
Establishment of Protocols for Global Metabolomics by LC-MS for Biomarker Discovery
por: Saigusa, Daisuke, et al.
Publicado: (2016) -
UPLC-MS/MS-Based Serum Metabolomics Signature as Biomarkers of Esophagogastric Variceal Bleeding in Patients With Cirrhosis
por: Ai, Yingjie, et al.
Publicado: (2022) -
Organization of GC/MS and LC/MS metabolomics data into chemical libraries
por: DeHaven, Corey D, et al.
Publicado: (2010) -
Integrated LC-MS/MS system for plant metabolomics
por: Sawada, Yuji, et al.
Publicado: (2013)